Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Levopropoxyphennapsilat
2. Prestwick0_001054
3. Prestwick1_001054
4. Prestwick2_001054
5. Prestwick3_001054
6. Bspbio_001008
7. Spbio_002934
8. Bpbio1_001110
9. Chembl4303291
10. Chebi:94397
11. Hms1571c10
12. Hms2098c10
13. Hms3715c10
14. Ccg-221054
15. Ncgc00180923-01
16. Sr-01000872689
17. Sr-01000872689-1
18. Q27166247
19. [4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] Propanoate;naphthalene-2-sulfonic Acid
| Molecular Weight | 547.7 g/mol |
|---|---|
| Molecular Formula | C32H37NO5S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 10 |
| Exact Mass | 547.23924445 g/mol |
| Monoisotopic Mass | 547.23924445 g/mol |
| Topological Polar Surface Area | 92.3 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 688 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
FDF Dossiers
Regulatory Info : DISCN
Registration Country : USA
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
Brand Name : NOVRAD
Dosage Form : SUSPENSION;ORAL
Dosage Strength : EQ 50MG BASE/5ML
Packaging :
Approval Date : 1982-01-01
Application Number : 12928
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
Brand Name : NOVRAD
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 12928
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
Brand Name : NOVRAD
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 12928
Regulatory Info : DISCN
Registration Country : USA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
RLD : No
TE Code :
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
Brand Name : NOVRAD
Dosage Form : SUSPENSION;ORAL
Dosage Strength : EQ 50MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 12928
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
Brand Name : NOVRAD
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 1982-01-01
Application Number : 12928
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS
Brand Name : NOVRAD
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Approval Date : 1982-01-01
Application Number : 12928
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Regretos manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Regretos, including repackagers and relabelers. The FDA regulates Regretos manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Regretos API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Regretos supplier is an individual or a company that provides Regretos active pharmaceutical ingredient (API) or Regretos finished formulations upon request. The Regretos suppliers may include Regretos API manufacturers, exporters, distributors and traders.
Regretos Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Regretos GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Regretos GMP manufacturer or Regretos GMP API supplier for your needs.
A Regretos CoA (Certificate of Analysis) is a formal document that attests to Regretos's compliance with Regretos specifications and serves as a tool for batch-level quality control.
Regretos CoA mostly includes findings from lab analyses of a specific batch. For each Regretos CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Regretos may be tested according to a variety of international standards, such as European Pharmacopoeia (Regretos EP), Regretos JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Regretos USP).
LOOKING FOR A SUPPLIER?
